Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China
Liu Q, Lu P, Shen Y, Li C, Wang J, Zhu L, Lu W, Martinez L
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021-08
Abstract
The coronavirus disease 2019 (COVID-19) pandemic may impede global tuberculosis elimination goals. In Jiangsu Province, China, tuberculosis notifications dropped 52% in 2020 compared to 2015-2019. Treatment completion and screening for drug resistance decreased continuously in 2020. Urgent attention must be paid to tuberculosis control efforts during and after the COVID-19 pandemic.
MeSH terms
- Humans
- Tuberculosis
- China
- Pandemics
- COVID-19
- SARS-CoV-2